Philips Reinforces Leadership in Image-Guided Therapy Solutions with Global Launch of Next Generation Azurion Platform
February 22 2017 - 11:15AM
Business Wire
- Developed in collaboration with leading
hospitals worldwide, Philips Azurion is an innovative image-guided
therapy platform that allows clinicians to easily and confidently
perform a wide range of routine and complex procedures, helping
them to optimize interventional lab performance and provide
superior care
- Azurion is powered by ConnectOS,
Philips’ newly developed operating system to optimize system
integration which features an easy-to-use intuitive user interface
combined with real-time information on multiple work spots within
the interventional lab
Royal Philips (NYSE:PHG, AEX:PHIA), a leader in health
technology, today announced the global launch of Azurion, its next
generation image-guided therapy platform, which forms the new core
of its integrated solutions portfolio for the fast growing
image-guided therapy market. As a leader in this market, Philips
offers integrated solutions comprising interventional imaging
technologies and planning and navigation software combined with
interventional devices - including catheters for diagnosis and
therapy - and a broad range of services, all aimed at helping
clinicians to provide superior care at predictable costs.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170222005353/en/
Azurion is Philips' next generation
image-guided therapy platform and the new core of its integrated
solutions portfolio. Azurion supports a full range of
configurations across a broad spectrum of image-guided therapy
procedures. These include configurations for high volume routine
procedures and flexible configurations for advanced procedures.
Harnessing vital procedural information from various sources, such
as imaging systems, interventional devices, navigation tools and
patient health records, Azurion provides interventional staff
members with the control and information they need to perform
procedures efficiently. (Photo: Business Wire)
Following the acquisition of Volcano in 2015, via which Philips
has become a leader in advanced catheters for diagnosis and
therapy, the company is now further cementing its overall
leadership in the EUR 5 billion image-guided therapy market with
one of its largest global product launches in recent years.
Philips’ Azurion image-guided therapy platform for interventional
labs is the result of a multi-year development program conducted in
close collaboration with leading clinicians in the field. This next
generation platform features a state-of-the-art ergonomic design
with an easy-to-use intuitive user interface, enabling clinicians
to swiftly and confidently perform a wide range of routine and
complex procedures in the interventional lab.
With the rapid growth of image-guided therapy procedures,
hospitals and health systems are increasingly faced with the need
to control costs, while improving their standards of care. Azurion
has been designed to address these challenges and is equipped with
new workflow options and performance dashboards, as well as an
upcoming range of productivity improvement services.
The Azurion platform also features over 1,000 new components,
including an enhanced flat-panel detector, and Philips’ newly
developed ConnectOS operating system for the seamless integration
of real-time information from all relevant technologies in the
interventional lab. All of these components work together to
deliver high image quality at ultra-low X-ray dose and real-time
image processing on multiple work spots within the interventional
lab. Parallel working enables the team of clinicians to complete
different tasks simultaneously in the interventional lab, saving
valuable time without compromising quality of care. Azurion
features procedure cards that allow clinicians to pre-program
routine tasks and user preferences, helping to minimize preparation
errors and further reducing preparation and procedure time.
Philips has pioneered a steady stream of innovations in planning
and navigation software for areas such as vascular surgery (e.g.
VesselNavigator), interventional cardiology (e.g. EchoNavigator),
interventional oncology (e.g. EmboGuide), and interventional
neuroradiology (e.g. AneurysmFlow). All these advanced
interventional tools integrate seamlessly into the Azurion platform
to support the clinical workflow.
Driven by their benefits for patients and care providers,
minimally-invasive therapies, such as the catheter-based treatment
of certain tumors, aneurysms, obstructed blood vessels, heart
rhythm disorders and defective heart valves, continue to grow fast.
In addition to reduced patient trauma and shorter recovery times,
such procedures also have the benefit of allowing the treatment of
patients who would not be able to withstand the trauma of open
surgery. However, during such procedures, clinicians cannot
directly see and feel the organs they are working on. Effective
imaging, measurement and navigation technologies are therefore key
to guiding minimally-invasive procedures. At the heart of the
interventional lab, these technologies allow identification and
visualization of target organs and tissues, the operation of
interventional devices, and the placement of implants, leading to
improved chances of therapy success.
“For over 30 years, we’ve pioneered minimally-invasive
treatments that help our patients get back to their daily lives,”
said Barry T. Katzen, MD, founder and Chief Medical Executive of
the Miami Cardiac & Vascular Institute, Baptist Health South
Florida (U.S.). “The imaging environment is critical to perform
such procedures efficiently and effectively. As an
interventionalist, we want to be in the cockpit, similar to a pilot
in an airplane, where we have control of everything we need and
have all the relevant functions at our finger tips. Philips’ next
generation image-guided therapy platform just takes it to a whole
other level and allows interventionalists to accomplish the
procedures quicker and more efficiently, which benefits the
patient."
“As a leader in image-guided therapy, we have been driving
continuous innovation to address rising patient volumes and
increased procedure complexity,” said Bert van Meurs, Business
Leader Image Guided Therapy at Philips. “Hundreds of Philips
developers, engineers and designers and dozens of our clinical
partners across the world have collaborated to completely redesign
the heart of our portfolio. With the launch of our new Azurion
platform, which was designed to optimize system integration and lab
performance, we can deliver new turnkey solutions that support our
customers in maintaining high standards of quality and patient care
at predictable costs.”
“We are on an exciting journey to strengthen the Tampere Heart
Hospital’s position as a Northern European center of excellence for
cardiac care,” said Aki Haukilahti, Executive Vice President and
CFO of Heart Hospital, Tampere University Hospital (Finland). “As
part of our long-term strategic partnership with Philips, we have
collaborated on a turnkey solution based on the new Azurion product
family. With this solution, Philips provides us with advanced
technologies and an excellent user experience, combined with
services for guaranteed uptime, seamless integration into our
hospital workflows, staff training and education, and enhancement
of our productivity. This enables our staff to fully focus on what
they do best – providing superior care to our patients.”
Click on this link or type www.philips.com/azurion in your
internet browser to visit the Philips Azurion website.
About Royal Philips
Royal Philips (NYSE:PHG, AEX:PHIA) is a leading health
technology company focused on improving people’s health and
enabling better outcomes across the health continuum from
healthy living and prevention, to diagnosis, treatment and home
care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as
in consumer health and home care. Philips’ health
technology portfolio generated 2016 sales of EUR 17.4 billion and
employs approximately 71,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170222005353/en/
Philips Image Guided TherapyFabienne van der Feer, + 31 6
22698001fabienne.van.der.feer@philips.comorPhilips Group
CommunicationsSteve Klink, +31 6
10888824steve.klink@philips.com
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Sep 2023 to Sep 2024